Company Filing History:
Years Active: 2013
Title: The Innovative Contributions of Jacqueline Nuss Parker
Introduction
Jacqueline Nuss Parker is a prominent inventor based in Birmingham, AL (US). She has made significant strides in the field of cancer treatment through her innovative research and development. Her work focuses on utilizing viral vectors to enhance anti-cancer therapies, showcasing her commitment to advancing medical science.
Latest Patents
Jacqueline Nuss Parker holds a patent for a groundbreaking invention titled "Herpes simplex virus expressing foreign genes and method for treating cancers therewith." This anti-cancer pharmaceutical composition incorporates a herpes simplex virus (HSV) vector that has been engineered to include a nucleic acid sequence encoding for an anti-cancer agent. The agents selected for this composition include interleukin-12, GM-CSF, and CD. The method of treatment involves administering this HSV vector to patients suffering from cancer, providing a novel approach to cancer therapy.
Career Highlights
Throughout her career, Jacqueline has demonstrated exceptional dedication to her research. Her work has not only contributed to the scientific community but has also paved the way for new treatment options for cancer patients. She is affiliated with the UAB Research Foundation, where she continues to explore innovative solutions in the field of oncology.
Collaborations
Jacqueline has collaborated with esteemed colleagues such as Richard J. Whitley and James MacDowell Markert. These partnerships have further enriched her research and have led to advancements in the understanding and treatment of cancer.
Conclusion
Jacqueline Nuss Parker's contributions to cancer research through her innovative patent highlight her role as a leading inventor in the medical field. Her work exemplifies the potential of combining viral vectors with therapeutic agents to create effective cancer treatments.